Current treatment of non‐alcoholic fatty liver disease

R Paternostro, M Trauner - Journal of internal medicine, 2022 - Wiley Online Library
Non‐alcoholic fatty liver disease (NAFLD) comprises a wide spectrum of pathologies
ranging from non‐alcoholic fatty liver (NAFL), characterized by simple steatosis without …

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

A Vogel, A Cervantes, I Chau, B Daniele… - Annals of …, 2018 - annalsofoncology.org
The incidence of hepatocellular carcinoma (HCC) has been rising worldwide over the last
20 years and is expected to increase until 2030 in some countries including the United …

[HTML][HTML] The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver …

M Eslam, SK Sarin, VWS Wong, JG Fan… - Hepatology …, 2020 - Springer
Metabolic associated fatty liver disease (MAFLD) is the principal worldwide cause of liver
disease and affects nearly a quarter of the global population. The objective of this work was …

Update to the society of radiologists in ultrasound liver elastography consensus statement

RG Barr, SR Wilson, D Rubens, G Garcia-Tsao… - Radiology, 2020 - pubs.rsna.org
This multidisciplinary update of the Society of Radiologists in Ultrasound consensus
statement on liver elastography incorporates the large volume of new information available …

Liver cirrhosis

P Ginès, A Krag, JG Abraldes, E Solà, N Fabrellas… - The Lancet, 2021 - thelancet.com
Cirrhosis is widely prevalent worldwide and can be a consequence of different causes, such
as obesity, non-alcoholic fatty liver disease, high alcohol consumption, hepatitis B or C …

[HTML][HTML] Liver ultrasound elastography: an update to the world federation for ultrasound in medicine and biology guidelines and recommendations

G Ferraioli, VWS Wong, L Castera, A Berzigotti… - Ultrasound in medicine …, 2018 - Elsevier
Abstract The World Federation for Ultrasound in Medicine and Biology has produced these
guidelines for the use of elastography techniques in liver diseases. For each available …

Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease

M Papatheodoridi, JB Hiriart, M Lupsor-Platon… - Journal of …, 2021 - Elsevier
Background The Baveno VI consensus proposed a dual liver stiffness (LS) by transient
elastography threshold of< 10 and> 15 kPa for excluding and diagnosing compensated …

Noninvasive diagnosis of portal hypertension in patients with compensated advanced chronic liver disease

M Pons, S Augustin, B Scheiner… - Official journal of the …, 2021 - journals.lww.com
METHODS: This is an international cohort study including patients with paired LSM/hepatic
venous pressure gradient (HVPG), LSM≥ 10 kPa, and no previous decompensation. Portal …

[HTML][HTML] Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a …

LT Chen, E Martinelli, AL Cheng, G Pentheroudakis… - Annals of …, 2020 - Elsevier
The most recent version of the European Society for Medical Oncology (ESMO) Clinical
Practice Guidelines for the diagnosis, treatment and follow-up of hepatocellular carcinoma …

Portal hypertension: pathogenesis and diagnosis

L Turco, G Garcia-Tsao - Clinics in liver disease, 2019 - liver.theclinics.com
Portal Hypertension - Clinics in Liver Disease Skip to Main Content Skip to Main Menu
Advertisement Clinics in Liver Disease Log in Register Log in Subscribe Claim Cart (1 item) …